Illumina Body Map 2
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
GATA5 | hg19_v2_chr20_-_61051026_61051057 | -0.28 | 1.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_+_155484155 Show fit | 8.73 |
ENST00000509493.1
|
fibrinogen beta chain |
|
chr4_+_155484103 Show fit | 7.54 |
ENST00000302068.4
|
fibrinogen beta chain |
|
chr4_-_72649763 Show fit | 5.77 |
ENST00000513476.1
|
group-specific component (vitamin D binding protein) |
|
chr1_+_57320437 Show fit | 5.62 |
ENST00000361249.3
|
complement component 8, alpha polypeptide |
|
chr15_-_54025300 Show fit | 4.13 |
ENST00000559418.1
|
WD repeat domain 72 |
|
chr21_+_39668478 Show fit | 4.01 |
ENST00000398927.1
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
|
chr5_+_75904918 Show fit | 3.91 |
ENST00000514001.1
ENST00000396234.3 ENST00000509074.1 |
IQ motif containing GTPase activating protein 2 |
|
chr5_+_75904950 Show fit | 3.58 |
ENST00000502745.1
|
IQ motif containing GTPase activating protein 2 |
|
chr2_+_102615416 Show fit | 3.08 |
ENST00000393414.2
|
interleukin 1 receptor, type II |
|
chr10_+_7745303 Show fit | 3.05 |
ENST00000429820.1
ENST00000379587.4 |
inter-alpha-trypsin inhibitor heavy chain 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 16.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.3 | 7.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.3 | 6.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 6.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 5.8 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 5.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.4 | 4.8 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 4.1 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 4.0 | GO:0010107 | potassium ion import(GO:0010107) |
0.8 | 3.1 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 16.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 12.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 8.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 6.1 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.6 | 5.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.9 | 2.7 | GO:0005960 | glycine cleavage complex(GO:0005960) |
0.0 | 2.3 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 2.2 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 2.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 2.0 | GO:0000800 | lateral element(GO:0000800) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 16.4 | GO:0051087 | chaperone binding(GO:0051087) |
0.5 | 7.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 6.5 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 6.1 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
1.9 | 5.8 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.4 | 4.8 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 4.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 4.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.6 | 3.1 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.5 | 2.8 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 16.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 4.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 4.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 3.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 1.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 1.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 1.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 1.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 1.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 16.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 6.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 5.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 4.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 3.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 2.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 2.4 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 2.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 2.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 1.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |